Security key
N69605108
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Total 13F shares
- 22,314,954
- Total 13F value
- $173,600,000
- Share change
- -38,384
- SEC-reported price per share
- $7.67
- Number of holders
- 21
- Value change
- -$317,120
- Number of buys
- 8
- Number of sells
- 6
- Shares outstanding
- 65,237,679
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2022
Institutions
21
Top holders
10
PHVS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Pharvaris N.V. SEC filings
Pharvaris N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N69605108
Recent filing periods:
Ownership snapshot
Top reported holders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
5.1%
Foresite Capital Management IV, LLC
5%
Bain Capital Life Sciences Invest...
4.9%
VIKING GLOBAL INVESTORS LP
3.8%
GENERAL ATLANTIC, L.P.
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
5.1%
|
$73,265,000
3,315,188 shares
|
— | 30 Jun 2022 |
| Foresite Capital Management IV, LLC |
13F
Company
|
5%
|
$71,757,000
3,246,926 shares
|
— | 30 Jun 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
4.9%
|
$70,291,000
3,180,601 shares
|
— | 30 Jun 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
3.8%
|
$55,071,000
2,491,923 shares
|
— | 30 Jun 2022 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
3.7%
|
$53,485,000
2,420,155 shares
|
— | 30 Jun 2022 |
| venBio Partners LLC |
13F
Company
|
3.5%
|
$50,862,000
2,301,451 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
22,314,954
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
20
Q3 2022 holders
21
Holder diff
1
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend